Maximus (MMS)
(Delayed Data from NYSE)
$90.10 USD
+1.55 (1.75%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $90.08 -0.02 (-0.02%) 7:58 PM ET
2-Buy of 5 2
B Value C Growth F Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$90.10 USD
+1.55 (1.75%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $90.08 -0.02 (-0.02%) 7:58 PM ET
2-Buy of 5 2
B Value C Growth F Momentum B VGM
Zacks News
Maximus (MMS) Tops Q3 Earnings Estimates
by Zacks Equity Research
Maximus (MMS) delivered earnings and revenue surprises of 4.30% and -3.45%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Delphi Technologies (DLPH) Misses on Q2 Earnings, Tweaks View
by Zacks Equity Research
Delphi Technologies (DLPH) second-quarter 2019 earnings hurt by unfavorable product mix decreased volume and unfavorable currency exchange movements.
FLEETCOR (FLT) Q2 Earnings & Revenues Beat, 2019 View Up
by Zacks Equity Research
FLEETCOR (FLT) second-quarter 2019 earnings and revenues improve year over year.
Stericycle (SRCL) Q2 Earnings Miss Estimates, Revenues Beat
by Zacks Equity Research
Stericycle's (SRCL) second-quarter 2019 results reflect negative impacts of foreign exchange rates, lower SOP pricing, and higher operating costs.
Maximus (MMS) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Maximus (MMS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
5 Reasons to Have MAXIMUS (MMS) Stock in Your Portfolio
by Zacks Equity Research
MAXIMUS (MMS) continues to focus on digital transformation, clinical evolution and market expansion. The acquisition of General Dynamics Information Technology's citizen engagement centers bodes well.
Booz Allen (BAH) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Booz Allen (BAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
The Zacks Analyst Blog Highlights: Kelly Services, NV5 Global, Limbach, MAXIMUS and First American Financial
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Kelly Services, NV5 Global, Limbach, MAXIMUS and First American Financial
US Threatens More Tariffs on EU Goods: 5 Big Gainers
by Tirthankar Chakraborty
The Trump administration proposes an additional $4 billion in tariffs on EU goods to bend a 15-year disagreement over aircraft subsidiary.
Government Services Industry Momentum Continues: 3 Top Picks
by Shuvra Shankar Dey
The bipartisan budget agreement encouraging several federal bodies to increase their spending is driving contract win rates of industry players.
Zacks.com featured highlights include: Lithia Motors, OUTFRONT, Lockheed, Maximus and Microsoft
by Zacks Equity Research
Zacks.com featured highlights include: Lithia Motors, OUTFRONT, Lockheed, Maximus and Microsoft
6 Top Dividend Stock Picks for Growth
by Sweta Killa
Investors can enjoy rising current income with dividend stocks, while anticipating capital appreciation irrespective of market conditions.
Maximus (MMS) Up 3.3% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Maximus (MMS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
6 Reasons Why MAXIMUS (MMS) Should Be in Your Portfolio
by Zacks Equity Research
MAXIMUS (MMS) continues to execute on its three-pronged strategy of digital transformation, clinical evolution and market expansion.
Booz Allen (BAH) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Booz Allen (BAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
MAXIMUS (MMS) Benefits From Three-Pronged Strategy, Buyouts
by Zacks Equity Research
Digital transformation strategies and expansion of clinical-related services ensure long-term sustainable growth for MAXIMUS (MMS). Acquisitions act as another key growth catalyst.
MAXIMUS (MMS) Beats on Q2 Earnings, Narrows 2019 Guidance
by Zacks Equity Research
MAXIMUS's (MMS) second-quarter fiscal 2019 results benefit from the acquisition of citizen engagement centers.
Maximus (MMS) Q2 Earnings Beat Estimates
by Zacks Equity Research
Maximus (MMS) delivered earnings and revenue surprises of 16.30% and -3.87%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
WEX Beats on Q1 Earnings and Revenues, Raises 2019 View
by Zacks Equity Research
WEX's first-quarter 2019 revenues benefit from strong performance of Travel and Corporate Solutions and Health and Employee Benefit Solutions segments.
FLEETCOR (FLT) Q1 Earnings & Revenues Beat, 2019 View Up
by Zacks Equity Research
FLEETCOR (FLT) first-quarter 2019 earnings and revenues improve year over year.
Broadridge (BR) Tops Earnings Estimates in Q3, Lags Revenues
by Zacks Equity Research
Broadridge's (BR) third-quarter fiscal 2019 earnings and revenues increase year over year.
Gartner (IT) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Gartner (IT) first-quarter 2019 earnings decrease year over year while revenues improve.
ICF International (ICFI) Beats on Q1 Earnings and Revenues
by Zacks Equity Research
ICF International's (ICFI) first-quarter 2019 earnings and revenues increase year over year.
Maximus (MMS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Maximus (MMS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Should You Retain H&R Block (HRB) in Your Portfolio?
by Zacks Equity Research
Prudent investments should help H&R Block (HRB) achieve clients, revenue and earnings growth objectives.